US Stock MarketDetailed Quotes

GENE Genetic Technologies

Watchlist
  • 2.380
  • +0.125+5.56%
Close May 6 16:00 ET
9.16MMarket Cap-15761P/E (TTM)

About Genetic Technologies Company

Genetic Technologies Ltd. Is a molecular diagnostic company that provides predictive testing and assessment tools to help doctors proactively manage women's health. It operates in geographical segments in the United States and Australia. The company's product, BREVAGenplus, is a clinically proven non-hereditary breast cancer risk assessment test. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Company Profile

SymbolGENE
Company NameGenetic Technologies
Listing DateSep 2, 2005
Founded1987
CEOMr. Simon Morriss
MarketNASDAQ
Employees60
Securities TypeDR
ADS Ratio1.0 : 30.0
Fiscal Year Ends06-30
Address60-66 Hanover Street
CityFitzroy
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3065
Phone61-3-8412-7000

Company Executives

  • Name
  • Position
  • Salary
  • Kevin Camilleri
  • Chief Executive Officer, EasyDNA
  • 281.15K
  • Simon Morriss
  • Chief Executive Officer
  • 587.74K
  • Carl Stubbings
  • Chief Commercial Officer
  • 296.94K
  • Dr. Richard Allman
  • Chief Scientific Officer
  • 87.28K
  • Tony Di Pietro
  • Company Secretary and Chief Financial Officer
  • 184.43K
  • Peter Rubinstein
  • Non-Executive Chairman of the Board
  • 164.72K
  • Dr. Jerzy Muchnicki
  • Director
  • 64.46K
  • Nicholas Burrows
  • Independent Director
  • 74.55K
  • Dr. Lindsay P. Wakefield
  • Independent Director
  • 74.55K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg